Literature DB >> 28469787

miR-1231 exacerbates arrhythmia by targeting calciumchannel gene CACNA2D2 in myocardial infarction.

Jiefang Zhang1, Lili Wu1, Zhengwei Li1, Guosheng Fu1.   

Abstract

MicroRNAs (miRNAs) are noncoding single-stranded RNAs of ~22 nucleotides suppressing a wide range of gene expression by direct degradation or translational inhibition of their target mRNAs. Acute myocardial infarction (AMI), a common cardiovascular disease mainly induced by coronary artery occlusion, can lead to the development of heart failure. Several recent findings have indicated that miRNAs might play vital roles in AMI, and some miRNAs have even been proposed as potential candidates for intervening AMI. However, the pathophysiological functions of miRNAs implicated in MI are still largely unidentified. Here, we show that miR-1231 is overexpressed both in human hearts after MI insults and in rat hearts with experimental MI compared with their healthy counterparts. Next, by using predictive strategy and gene expression array, cacna2d2 is identified as the target of miR-1231. In human and rat ischemic hearts, cacna2d2 expression is indeed suppressed by miR-1231. In addition, the inhibition of miR-1231 in vivo ameliorates arrhythmias in rat MI hearts; conversely, the forced overexpression of miR-1231 promotes arrhythmias. Furthermore, cacna2d2 knockdown alone induced arrhythmias in ischemic hearts, despite knockdown of miR-1231. Thus, these results indicate that miR-1231 exacerbates arrhythmia by inhibiting cacna2d2 in ischemic heart, which shed light on the important arrhythmogenic function of miR-1231 in MI and suggest it may serve as a potential antiarrhythmic target.

Entities:  

Keywords:  Myocardial infarction; arrhythmia; cacna2d2; miR-1231; miRNAs

Year:  2017        PMID: 28469787      PMCID: PMC5411930     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  27 in total

Review 1.  MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment.

Authors:  Eva-Marie Heinrich; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

2.  MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction.

Authors:  Benjamin Meder; Andreas Keller; Britta Vogel; Jan Haas; Farbod Sedaghat-Hamedani; Elham Kayvanpour; Steffen Just; Anne Borries; Jessica Rudloff; Petra Leidinger; Eckart Meese; Hugo A Katus; Wolfgang Rottbauer
Journal:  Basic Res Cardiol       Date:  2010-10-01       Impact factor: 17.165

3.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing.

Authors:  Andrew Grimson; Kyle Kai-How Farh; Wendy K Johnston; Philip Garrett-Engele; Lee P Lim; David P Bartel
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

4.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

5.  Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2).

Authors:  B Gao; Y Sekido; A Maximov; M Saad; E Forgacs; F Latif; M H Wei; M Lerman; J H Lee; E Perez-Reyes; I Bezprozvanny; J D Minna
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

Review 6.  MicroRNAs in myocardial infarction.

Authors:  Reinier A Boon; Stefanie Dimmeler
Journal:  Nat Rev Cardiol       Date:  2014-12-16       Impact factor: 32.419

7.  Absence of calcium channel alpha1C-subunit mutation in human atrial fibrillation.

Authors:  Jia-Lin Soon; Liao Ping; Yeow-Leng Chua; Tuck-Wah Soong; Kenny Yoong-Kong Sin
Journal:  Asian Cardiovasc Thorac Ann       Date:  2010-08

8.  Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.

Authors:  M J Curtis; M J Walker
Journal:  Cardiovasc Res       Date:  1988-09       Impact factor: 10.787

9.  Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.

Authors:  Bianca C Bernardo; Xiao-Ming Gao; Catherine E Winbanks; Esther J H Boey; Yow Keat Tham; Helen Kiriazis; Paul Gregorevic; Susanna Obad; Sakari Kauppinen; Xiao-Jun Du; Ruby C Y Lin; Julie R McMullen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

10.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

View more
  4 in total

1.  CircNPHP4 in monocyte-derived small extracellular vesicles controls heterogeneous adhesion in coronary heart atherosclerotic disease.

Authors:  Feng Xiong; Rui Mao; Lijuan Zhang; Ruohan Zhao; Kunyue Tan; Chunxia Liu; JunBo Xu; Guanghong Du; Tongtong Zhang
Journal:  Cell Death Dis       Date:  2021-10-14       Impact factor: 8.469

2.  ZNF561-AS1 Regulates Cell Proliferation and Apoptosis in Myocardial Infarction Through miR-223-3p/NLRP3 Axis.

Authors:  Xiaoyu Li; Jun Long; Ligeng Zong; Chengcheng Zhang; Zhongxin Yang; Shengnan Guo
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 3.  Cell type-specific microRNA therapies for myocardial infarction.

Authors:  Bohao Liu; Bryan Wang; Xiaokan Zhang; Roberta Lock; Trevor Nash; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

4.  Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation.

Authors:  Joana Larupa Santos; Ismael Rodríguez; Morten S Olesen; Bo Hjorth Bentzen; Nicole Schmitt
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.